Search Results - "NUMIS, F. G"

Eculizumab treatment in patients with COVID-19: preliminary results from real life ASL Napoli 2 Nord experience by Diurno, F, Numis, F G, Porta, G, Cirillo, F, Maddaluno, S, Ragozzino, A, De Negri, P, Di Gennaro, C, Pagano, A, Allegorico, E, Bressy, L, Bosso, G, Ferrara, A, Serra, C, Montisci, A, D'Amico, M, Schiano Lo Morello, S, Di Costanzo, G, Tucci, A G, Marchetti, P, Di Vincenzo, U, Sorrentino, I, Casciotta, A, Fusco, M, Buonerba, C, Berretta, M, Ceccarelli, M, Nunnari, G, Diessa, Y, Cicala, S, Facchini, G

“…SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2)-related pneumonia, referred to as COVID-19 (Coronavirus Disease 19), is a public health emergency…”
Get more information

Association between vitamin D receptor gene polymorphisms and tubular citrate handling in calcium nephrolithiasis by Mossetti, G., Vuotto, P., Rendina, D., Numis, F. G., Viceconti, R., Giordano, F., Cioffi, M., Scopacasa, F., Nunziata, V.

“… Mossetti G, Vuotto P, Rendina D, Numis FG, Viceconti R, Giordano F, Cioffi M, Scopacasa F, Nunziata V (Federico II University Medical School, Naples, Italy)…”
Get full text

Non-invasive CPAP in mild and moderate ARDS secondary to SARS-CoV-2 by Pagano, A., Porta, G., Bosso, G., Allegorico, E., Serra, C., Dello Vicario, F., Minerva, V., Russo, T., Altruda, C., Arbo, P., Mercurio, V., Numis, F.G.

“…•Helmet CPAP is effective to treat mild and moderate ARDS secondary to SARS COV 2.•Lung recruitment is not the only pathological mechanism responsible of CPAP…”
Get full text

Blood lactate in mild and moderate ARDS secondary to SARS COV 2 by Pagano, A., Porta, G., Bosso, G., Allegorico, E., Serra, C., Mercurio, V., Sansone, G., Orefice, S., Numis, F.G.

“…Elevated blood lactate levels are associated with poor outcome in several critical conditions. Patients with SARS-CoV-2 rarely develop hyperlactatemia. The…”
Get full text

In the face of the SARS-CoV-2 outbreak, do people suffering from oncological disease need specific attention? by Carta, M G, Orrù, G, Scano, A, Coghe, F, Nunnari, G, Facchini, G, Numis, F G, Berretta, M

Get more information

Application and internal validation of lung ultrasound score in COVID-19 setting: The ECOVITA observational study by Rinaldi, L., Lugarà, M., Simeon, V., Perrotta, F., Romano, C., Iadevaia, C., Sagnelli, C., Monaco, L., Altruda, C., Fascione, M.C., Restivo, L., Scognamiglio, U., Laganà, N., Nevola, R., Oliva, G., Coppola, M.G., Acierno, C., Masini, F., Pinotti, E., Allegorico, E., Tamburrini, S., Vitiello, G., Niosi, M., Burzo, M.L., Franci, G., Perrella, A., Signoriello, G., Frusci, V., Mancarella, S., Loche, G., Pellicano, G.F., Berretta, M., Calabria, G., Pietropaolo, L., Numis, F.G., Coppola, N., Corcione, A., Marfella, R., Adinolfi, L.E., Bianco, A., Sasso, F.C., de Sio, I.

“…The severe acute respiratory syndrome Coronarovirus-2 associated still causes a significant number of deaths and hospitalizations mainly by the development of…”
Get full text

Biochemical markers of bone turnover, serum levels of interleukin-6/interleukin-6 soluble receptor and bisphosphonate treatment in erdheim-chester disease by MOSSETTI, G, RENDINA, D, NUMIS, F. G, SOMMA, P, POSTIGLIONE, L, NUNZIATA, V

“…Erdheim-Chester disease (ECD) is a rare non-Langherans form of histiocytosis characterized radiologically by symmetrical sclerosis of the metaphysis and the…”
Get full text

Clodronate treatment reduces serum levels of interleukin-6 soluble receptor in Paget's disease of bone by RENDINA, D, POSTIGLIONE, L, VUOTTO, P, NUMIS, F. G, DI DOMENICO, G, VICECONTI, R, MOSSETTI, G, NUNZIATA, V

“…Interleukin-6 (IL-6) and its soluble receptor (sIL-6R) stimulate osteoclast formation and activity. The primary cell abnormality in Paget's disease of bone…”
Get full text

Raloxifene administration in post‐menopausal women with osteoporosis: effect of different BsmI vitamin D receptor genotypes by Palomba, Stefano, Numis, Fabio Giuliano, Mossetti, Giuseppe, Rendina, Domenico, Vuotto, Pietro, Russo, Tiziana, Zullo, Fulvio, Nappi, Carmine, Nunziata, Vincenzo

“…BACKGROUND: The vitamin D receptor (VDR) gene polymorphism has been considered a factor influencing the effectiveness of the anti‐osteoporotic treatments. The…”
Get full text

Effectiveness of alendronate treatment in postmenopausal women with osteoporosis: relationship with BsmI vitamin D receptor genotypes by Palomba, Stefano, Numis, Fabio Giuliano, Mossetti, Giuseppe, Rendina, Domenico, Vuotto, Pietro, Russo, Tiziana, Zullo, Fulvio, Nappi, Carmine, Nunziata, Vincenzo

“…Summary objective To assess whether there is a relationship between the effectiveness of alendronate treatment in postmenopausal women with osteoporosis and…”
Get full text

GH secretion after pharmacological tests (GHRH, clonidine and GHRH+pyridostigmine) both in GH deficient patients and severe obesity by Orio, F, Caggiano, D, Cittadini, A, Dentico, C, Di Rella, F, Di Seranno, A, Longobardi, S, Merola, B, Numis, FG, Orio, F, Tenuta, M

Get full text